drugset / Trial / NCT05893576
A Relative Bioavailability Study of HRS9531 in Healthy Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the relative bioavailability of the new formulation of HRS9531 injection between the original formulation of HRS9531 injection.
Timeline
- Start
- 2023-05-15
- Primary completion
- 2023-09-04
- Completion
- 2023-09-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS9531 | Unknown | — | — |